Scott Turner

Scott Turner serves as the Chief Scientific Officer at Arda Therapeutics since May 2024. Prior to this role, Scott was the Chief Scientific Officer at Pliant Therapeutics from September 2016 to February 2024, where additional titles included Senior Vice President, Head of Research, Vice President of Translational Sciences, and Senior Director. Earlier in the career, Scott held the position of Executive Vice President of Research and Development at KineMed Inc. from January 2002 to April 2016. Scott Turner earned a Doctor of Philosophy (PhD) in Nutrition Sciences and Toxicology from the University of California, Berkeley, and a Bachelor's degree in Biochemistry from the University of California, Santa Cruz.